Antithrombin Deficiency

Antithrombin deficiency is a rare inherited or acquired condition that affects the body's ability to control blood clotting. It involves the blood clotting system, specifically a protein called antithrombin that normally helps prevent excessive clot formation. When antithrombin levels are low or the protein does not work properly, blood clots can form too easily, leading to an increased risk of dangerous clots in veins, such as deep vein thrombosis or pulmonary embolism. This condition primarily impacts the circulatory system and can cause symptoms like swelling, pain, or redness in the affected limbs. People with this deficiency may experience recurrent or unusual blood clots, sometimes at a young age. Understanding this condition helps explain why some individuals have a higher tendency to develop blood clots without obvious triggers.

Antithrombin deficiency is a hereditary or acquired disorder characterized by a quantitative or qualitative defect in the antithrombin protein, a key endogenous inhibitor of coagulation proteases such as thrombin and factor Xa. The deficiency results from mutations in the SERPINC1 gene or from conditions that consume or reduce antithrombin levels, leading to a hypercoagulable state. This increases the risk of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, often presenting at a younger age than typical VTE cases. The deficiency is classified into type I (reduced antithrombin levels) and type II (normal levels but dysfunctional protein). It is clinically significant due to its association with recurrent thrombosis and potential resistance to standard anticoagulant therapy. Diagnosis and management are critical to prevent life-threatening thrombotic events.